{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:17:33Z","timestamp":1767374253164,"version":"3.37.3"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T00:00:00Z","timestamp":1725494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970434","81970434"],"award-info":[{"award-number":["81970434","81970434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-024-04148-8","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T07:03:13Z","timestamp":1725519793000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Coronary thrombosis and myocardial ischemia in Kawasaki disease: a case report"],"prefix":"10.1186","volume":"24","author":[{"given":"Lichao","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songling","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangqi","family":"Gong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,5]]},"reference":[{"key":"4148_CR1","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.ijcard.2019.10.045","volume":"307","author":"A Dionne","year":"2020","unstructured":"Dionne A, Dahdah N, Singh-Grewal D, Burgner DP, Newburger JW, de Ferranti SD. Anti-thrombosis management of patients with Kawasaki disease: results from an international survey. Int J Cardiol. 2020;307:154\u20138.","journal-title":"Int J Cardiol"},{"issue":"1","key":"4148_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1253\/circj.CJ-17-0433","volume":"82","author":"R Fukazawa","year":"2017","unstructured":"Fukazawa R, Kobayashi T, Mikami M, Saji T, Hamaoka K, Kato H, Suzuki H, Tsuda E, Ayusawa M, Miura M, et al. Nationwide survey of patients with Giant Coronary Aneurysm secondary to Kawasaki Disease 1999\u20132010 in Japan. Circ J. 2017;82(1):239\u201346.","journal-title":"Circ J"},{"issue":"10","key":"4148_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11926-020-00941-4","volume":"22","author":"E Rife","year":"2020","unstructured":"Rife E, Gedalia A. Kawasaki Disease: an update. Curr Rheumatol Rep. 2020;22(10):75.","journal-title":"Curr Rheumatol Rep"},{"issue":"8","key":"4148_CR4","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1253\/circj.CJ-19-1094","volume":"84","author":"R Fukazawa","year":"2020","unstructured":"Fukazawa R, Kobayashi J, Ayusawa M, Hamada H, Miura M, Mitani Y, Tsuda E, Nakajima H, Matsuura H, Ikeda K, et al. JCS\/JSCS 2020 Guideline on diagnosis and management of Cardiovascular Sequelae in Kawasaki Disease. Circ J. 2020;84(8):1348\u2013407.","journal-title":"Circ J"},{"issue":"17","key":"4148_CR5","doi-asserted-by":"publisher","first-page":"e927","DOI":"10.1161\/CIR.0000000000000484","volume":"135","author":"BW McCrindle","year":"2017","unstructured":"McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, Baker AL, Jackson MA, Takahashi M, Shah PB, et al. Diagnosis, treatment, and long-term management of Kawasaki Disease: A Scientific Statement for Health professionals from the American Heart Association. Circulation. 2017;135(17):e927\u201399.","journal-title":"Circulation"},{"issue":"14","key":"4148_CR6","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1016\/j.jacc.2015.12.073","volume":"67","author":"JW Newburger","year":"2016","unstructured":"Newburger JW, Takahashi M, Burns JC. Kawasaki Disease. J Am Coll Cardiol. 2016;67(14):1738\u201349.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4148_CR7","doi-asserted-by":"publisher","first-page":"E147","DOI":"10.1111\/echo.12535","volume":"31","author":"F Ekici","year":"2014","unstructured":"Ekici F, Varan B, Kocabas A, Erdogan I, Eminoglu S, Aktas D. Multiple giant aneurysms and stenoses of the coronary and systemic arteries in an infant with kawasaki disease at the early stage of convalescent period. Echocardiography. 2014;31(5):E147\u201350.","journal-title":"Echocardiography"},{"issue":"22","key":"4148_CR8","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1161\/CIRCULATIONAHA.105.592865","volume":"113","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, Kobayashi T, Morikawa A. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation. 2006;113(22):2606\u201312.","journal-title":"Circulation"},{"issue":"46","key":"4148_CR9","doi-asserted-by":"publisher","first-page":"80722","DOI":"10.18632\/oncotarget.21083","volume":"8","author":"W Hua","year":"2017","unstructured":"Hua W, Sun Y, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F. A new model to predict intravenous immunoglobin-resistant Kawasaki disease. Oncotarget. 2017;8(46):80722\u20139.","journal-title":"Oncotarget"},{"issue":"5","key":"4148_CR10","first-page":"CD011188","volume":"5","author":"J Green","year":"2022","unstructured":"Green J, Wardle AJ, Tulloh RM. Corticosteroids for the treatment of Kawasaki disease in children. Cochrane Database Syst Rev. 2022;5(5):CD011188.","journal-title":"Cochrane Database Syst Rev"},{"key":"4148_CR11","unstructured":"Center for D, Treatment of Kawasaki Disease\/Children\u2019s Hospital of Shaanxi Provincial People\u2019s H, National Children\u2019s Medical Center\/Beijing Children, \u2018s Hospital CMU, Children\u2019s Hospital SJTUSoM, National Regional Medical Center\/Shengjing Hospital of China Medical U, National Clinical Key Specialty\/Department of Intensive Care Medicine SCs., Hospital, General Pediatric Group of Pediatrician Branch of Chinese Medical Doctor A, Expert Committee of Advanced Training for Pediatrician CM, Children\u2019s Health A : [Evidence-based guidelines for the diagnosis and treatment of Kawasaki disease in children in China (2023)]. Zhongguo Dang Dai Er Ke Za Zhi. 2023; 25(12):1198\u2009\u2013\u2009210."},{"issue":"10","key":"4148_CR12","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/INF.0000000000001951","volume":"37","author":"PN Jone","year":"2018","unstructured":"Jone PN, Anderson MS, Mulvahill MJ, Heizer H, Glode MP, Dominguez SR. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG alone as initial therapy in Children with Kawasaki Disease presenting with coronary artery lesions: is dual therapy more effective? Pediatr Infect Dis J. 2018;37(10):976\u201380.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"4148_CR13","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.21037\/tp-20-482","volume":"10","author":"D Li","year":"2021","unstructured":"Li D, Li X, Dou W, Zheng Y. The effectiveness of infliximab for Kawasaki disease in children: systematic review and meta-analysis. Transl Pediatr. 2021;10(5):1294\u2013306.","journal-title":"Transl Pediatr"},{"key":"4148_CR14","doi-asserted-by":"publisher","first-page":"1149519","DOI":"10.3389\/fped.2023.1149519","volume":"11","author":"Y Pan","year":"2023","unstructured":"Pan Y, Fan Q, Hu L. Treatment of immunoglobulin-resistant kawasaki disease: a bayesian network meta-analysis of different regimens. Front Pediatr. 2023;11:1149519.","journal-title":"Front Pediatr"},{"issue":"5","key":"4148_CR15","doi-asserted-by":"publisher","first-page":"e180030","DOI":"10.1001\/jamapediatrics.2018.0030","volume":"172","author":"M Miura","year":"2018","unstructured":"Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N, Fuse S, Hamaoka K, Hirono K, Kato T, et al. Association of Severity of Coronary Artery Aneurysms in patients with Kawasaki Disease and Risk of later coronary events. JAMA Pediatr. 2018;172(5):e180030.","journal-title":"JAMA Pediatr"},{"issue":"1","key":"4148_CR16","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13052-021-00962-4","volume":"47","author":"A Marchesi","year":"2021","unstructured":"Marchesi A, Rigante D, Cimaz R, Ravelli A, Tarissi de Jacobis I, Rimini A, Cardinale F, Cattalini M, De Zorzi A, Dellepiane RM, et al. Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease. Ital J Pediatr. 2021;47(1):16.","journal-title":"Ital J Pediatr"},{"issue":"5","key":"4148_CR17","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1182\/blood.2019001847","volume":"135","author":"C Witmer","year":"2020","unstructured":"Witmer C, Raffini L. Treatment of venous thromboembolism in pediatric patients. Blood. 2020;135(5):335\u201343.","journal-title":"Blood"},{"issue":"6","key":"4148_CR18","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1161\/STROKEAHA.116.015535","volume":"48","author":"PG Tepper","year":"2017","unstructured":"Tepper PG, Liu X, Hamilton M, Mardekian J, Petkun W, Tan W, Singer DE. Ischemic stroke in Nonvalvular Atrial Fibrillation at Warfarin initiation: Assessment via a large insurance database. Stroke. 2017;48(6):1487\u201394.","journal-title":"Stroke"},{"issue":"10","key":"4148_CR19","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1016\/j.cjca.2020.01.016","volume":"36","author":"C Manlhiot","year":"2020","unstructured":"Manlhiot C, Newburger JW, Low T, Dahdah N, Mackie AS, Raghuveer G, Giglia TM, Dallaire F, Mathew M, Runeckles K, et al. Low-molecular-weight heparin vs warfarin for Thromboprophylaxis in Children with Coronary Artery aneurysms after Kawasaki Disease: a pragmatic Registry Trial. Can J Cardiol. 2020;36(10):1598\u2013607.","journal-title":"Can J Cardiol"},{"key":"4148_CR20","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.5114\/amsad\/161172","volume":"8","author":"H Patail","year":"2023","unstructured":"Patail H, Sharma T, Bali AD, Isath A, Aronow WS, Haidry SA. Dual antiplatelet therapy with concomitant anticoagulation: current perspectives on triple therapy. Arch Med Sci Atheroscler Dis. 2023;8:e13\u20138.","journal-title":"Arch Med Sci Atheroscler Dis"},{"key":"4148_CR21","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.ijcard.2020.07.022","volume":"321","author":"T Low","year":"2020","unstructured":"Low T, Jegatheeswaran A, Devlin PJ, Chahal N, Brandao LR, McCrindle BW. Bleeding risk associated with combination thromboprophylaxis therapy is low for patients with coronary artery aneurysms after Kawasaki disease. Int J Cardiol. 2020;321:6\u201311.","journal-title":"Int J Cardiol"},{"issue":"2","key":"4148_CR22","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s00246-010-9838-y","volume":"32","author":"E Tsuda","year":"2011","unstructured":"Tsuda E, Hirata T, Matsuo O, Abe T, Sugiyama H, Yamada O. The 30-year outcome for patients after myocardial infarction due to coronary artery lesions caused by Kawasaki disease. Pediatr Cardiol. 2011;32(2):176\u201382.","journal-title":"Pediatr Cardiol"},{"issue":"3","key":"4148_CR23","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1253\/circj.69.265","volume":"69","author":"Z Onouchi","year":"2005","unstructured":"Onouchi Z, Hamaoka K, Sakata K, Ozawa S, Shiraishi I, Itoi T, Kiyosawa N. Long-term changes in coronary artery aneurysms in patients with Kawasaki disease: comparison of therapeutic regimens. Circ J. 2005;69(3):265\u201372.","journal-title":"Circ J"},{"issue":"5","key":"4148_CR24","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1253\/circj.CJ-19-0133","volume":"83","author":"K Kimura","year":"2019","unstructured":"Kimura K, Kimura T, Ishihara M, Nakagawa Y, Nakao K, Miyauchi K, Sakamoto T, Tsujita K, Hagiwara N, Miyazaki S, et al. JCS 2018 Guideline on diagnosis and treatment of Acute Coronary Syndrome. Circ J. 2019;83(5):1085\u2013196.","journal-title":"Circ J"},{"issue":"11","key":"4148_CR25","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1016\/j.amjcard.2016.08.039","volume":"118","author":"JY Lo","year":"2016","unstructured":"Lo JY, Minich LL, Tani LY, Wilkes J, Ding Q, Menon SC. Factors Associated with Resource utilization and coronary artery dilation in Refractory Kawasaki Disease (from the Pediatric Health Information System Database). Am J Cardiol. 2016;118(11):1636\u201340.","journal-title":"Am J Cardiol"},{"issue":"1","key":"4148_CR26","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s12969-022-00767-7","volume":"20","author":"Y Chu","year":"2022","unstructured":"Chu Y, Xu Y, Wang C, Yu X, Ma Q, Wang H. Treatment of thrombosis in KD patients using tissue plasminogen activator: a single center study. Pediatr Rheumatol Online J. 2022;20(1):111.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"3","key":"4148_CR27","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1111\/ped.13783","volume":"61","author":"H Serizawa","year":"2019","unstructured":"Serizawa H, Lin L, Sato T, Takahashi-Igari M, Kato Y. Low-dose i.v. urokinase for coronary thrombosis in Kawasaki disease. Pediatr Int. 2019;61(3):302\u20133.","journal-title":"Pediatr Int"},{"issue":"3","key":"4148_CR28","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00246-014-1040-1","volume":"36","author":"H Peng","year":"2015","unstructured":"Peng H, Wu Z, Liu Y, Li L, Kong S, Wu J, Liu Y. Low-dose antithrombotic treatment in coronary thrombosis of Kawasaki disease. Pediatr Cardiol. 2015;36(3):503\u20138.","journal-title":"Pediatr Cardiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04148-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04148-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04148-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T07:06:37Z","timestamp":1725519997000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04148-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,5]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4148"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04148-8","relation":{},"ISSN":["1471-2261"],"issn-type":[{"type":"electronic","value":"1471-2261"}],"subject":[],"published":{"date-parts":[[2024,9,5]]},"assertion":[{"value":"7 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the medical ethics committee of the Children\u2019s Hospital of Zhejiang University School of Medicine (2021-IRB-217). The parents provided informed consent for this report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s parents for all the manuscripts that included images and details. The authors have deidentified patient-specific information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"473"}}